Leuprolide Acetate Injection Now Available

Share Facebook icon Twitter icon Linkedin icon
August 19, 2024

Meitheal Pharmaceuticals (Meitheal) is pleased to announce that we have launched Leuprolide Acetate Injection, 14 mg per 2.8 mL kits.

·        71288-569-90 - Leuprolide Acetate Injection 14 mg per 2.8 mL kit


ABOUT LEUPROLIDE ACETATE INJECTION, 14 MG PER 2.8 ML KIT

Leuprolide Acetate Injection is indicated for the palliative treatment of advanced prostatic cancer.

For full prescribing information, please click on the following link.

Learn more about Leuprolide Acetate Injection. 

New Launches
Eptifibatide Injection Now Available

Eptifibatide Injection Now Available

 Meitheal Pharmaceuticals Hosts 2nd Annual Golf Outing

Meitheal Pharmaceuticals Hosts 2nd Annual Golf Outing
This Website Uses Cookies

This website uses cookies to help give you the best experience when you visit. By clicking “Accept Cookies,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and help us make improvements to our site. You can read more about our use of cookies in our Privacy Policy.

Manage Consent Preferences

Always Active

Necessary cookies enable core functionality such as security and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

These cookies are set to provide quantitative measures of website visitors. Information collected with these cookies is used in operations to measure website performance. With the usage of these cookies we are able to count visits and traffic sources to improve our site. The data is collected in a way that does not directly identify anyone.
Accept all cookies Confirm my choices